| Barbara Adamson, | |
|
13704 W 78th St, Lenexa, KS 66216-3054 | |
| (913) 962-0313 | |
| Not Available |
| Full Name | Barbara Adamson |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 13704 W 78th St, Lenexa, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487935821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Adamson, 13704 W 78th St, Lenexa, KS 66216-3054 Ph: (913) 962-0313 | Barbara Adamson, 13704 W 78th St, Lenexa, KS 66216-3054 Ph: (913) 962-0313 |
News Archive
A key protein, which may be activated to protect nerve cells from damage during heart failure or epileptic seizure, has been found to regulate the transfer of information between nerve cells in the brain. The discovery, made by neuroscientists at the University of Bristol and published in Nature Neuroscience and PNAS, could lead to novel new therapies for stroke and epilepsy.
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of initial findings from their second clinical trial.
The following are summaries of several opinion pieces published in anticipation of the Child Survival Call to Action event to be held on June 14-15 in Washington, D.C. Convened by the Governments of United States, Ethiopia and India, and organized in close collaboration with UNICEF, the event will focus on ending preventable child death through the survival of newborns, children and mothers and will convene 700 prominent leaders from government, the private sector, faith-based organizations and civil society to kick off a long-term, focused effort to save children's lives.
Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer following surgery and initial treatment.
› Verified 7 days ago
Misha Khan, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Lenexa, KS 66214 Phone: 913-677-3553 | |
Rebecca Lynn Johnston, LMLP Counselor Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Lenexa, KS 66214 Phone: 913-677-3553 Fax: 913-677-3282 | |
Laura Mae Knight, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 12351 W 96th Ter Ste 108, Lenexa, KS 66215 Phone: 913-298-1907 | |
Christine Lopez, LMLP Counselor Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Lenexa, KS 66214 Phone: 913-677-3553 | |
Jessica M Rawlings, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 15717 College Blvd, Lenexa, KS 66219 Phone: 913-621-2016 Fax: 913-371-0509 | |
Joshua Tanguay, LMLP Counselor Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Suite 100, Lenexa, KS 66214 Phone: 913-677-3553 Fax: 913-677-3282 | |
Brittany Noel Loucks, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 12351 W 96th Ter Ste 108, Lenexa, KS 66215 Phone: 913-491-6876 |